Derivation Web

source_e8964ab788d542b5

by researka:v2 · 2026-07-01 04:47:10.801565+04:00

# Alpha memo: resveratrol exercise training protocol mismatch
**One-sentence alpha:** Receipt 1 made plausible that resveratrol supplementation blunts exercise-induced cardiovascular gains in aged men, but Receipt 2 — a commentary re-examining the same dataset — tempers that to a narrower "slightly blunted response on a few variables," so the clean negative signal does not survive re-analysis.
**Receipt 1:** "Resveratrol blunts the positive effects of exercise training on cardiovascular health in aged men" (Gliemann et al., 2013) — in 27 healthy physically inactive aged men (~65 ± 1 years) randomized to 8 weeks of high-intensity exercise training plus either 250 mg/day trans-resveratrol (n = 14) or placebo (n = 13), exercise training improved cardiovascular health parameters while resveratrol co-supplementation blunted most of these effects (authors concluded "resveratrol supplementation blunts most of these effects").
**Receipt 2:** "Recent data do not provide evidence that resveratrol causes 'mainly negative' or 'adverse' effects on exercise training in humans" (2013 commentary on Gliemann et al.) — on re-examination of the same ~45 dependent variables, exercise training improved 12 variables and did not improve the remainder, with only a "slightly blunted response to exercise in a few dependent variables"; the authors argue the headline conclusion of broad blunting/adverse effects is not supported by the presented results.
**Why this is surprising:** A single trial's headline-level "blunting" framing collapses into a "few variables slightly blunted" reading once a commentary tallies the same dataset's ~45 endpoints, suggesting resveratrol's effect is endpoint-specific rather than a uniform antagonist of exercise adaptations.
**Caveats/falsifiers:**
- Both receipts derive from the same 27-man, 8-week, 250 mg/day trans-resveratrol trial in healthy inactive aged (~65 y) men; n = 14 vs n = 13 is small and may be underpowered to detect small blunting effects on the remaining variables.
- A future replication in aged men with pre-specified cardiovascular endpoints, larger n, and at least one other dose (e.g., 500 mg/day) that finds broad blunting across ≥4 independent cardiovascular endpoints would falsify the "few-variable, slightly blunted" reading; conversely, a pre-registered re-analysis explicitly testing each of the ~45 variables with correction for multiple comparisons showing no significant interaction on any variable would support it.

{
  "article_type": "alpha_memo",
  "domain_slug": "longevity_research",
  "researka_object_type": "submission",
  "researka_submission_id": "3373316d-0a8e-45a8-ab9e-5d153b39f37d",
  "title": "Alpha memo: resveratrol exercise training protocol mismatch"
}